APTO

Aptose Biosciences Inc
0.6562
0.0861 (15.1%)

Aptose Biosciences Inc. (APTO) Fundamentals

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies.
SHARE INFORMATION
Market CapUS$ 53,992,419
Shares Outstanding92,367,275
Float91,044,246
Percent Float98.65%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions62
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months456,126
Institutional Holdings Percent34.7%
Institutional Sold Previous 3 Months1,754,557
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months2,050,000
Insider Holdings Percent1.9
Insider Sold Previous 3 Months-
Insider Shares Owned1,720,988
TRADING INFO
52 Week HighUS$ 1.55
52 Week LowUS$ 0.43
52 Week High ChangeUS$ -54.30
21 Day Moving AverageUS$ 0.5819
21 Day Extended Moving AverageUS$ 0.589701
50 Day Moving AverageUS$ 0.6497
50 Day Extended Moving AverageUS$ 0.617792
200 Day Moving AverageUS$ 0.687062
200 Day Extended Moving AverageUS$ 0.809315
10 Day Average Volume136,123
20 Day Average Volume118,657
30 Day Average Volume120,684
50 Day Average Volume188,478
Alpha-0.011869
Beta1.4868
Standard Deviation0.245122
R20.106697
7 Day Price ChangeUS$ 0.005
7 Day Percent Change0.86%
21 Day Price ChangeUS$ -0.0009
21 Day Percent Change-0.15%
30 Day Price ChangeUS$ -0.0501
30 Day Percent Change-7.89%
Month to Date Price ChangeUS$ 0.003
Month to Date Percent Change0.52%
Quarter to Date Price ChangeUS$ 0.005
Quarter to Date Percent Change0.86%
180 Day Price ChangeUS$ -0.02
180 Day Percent Change-3.31%
200 Day Price ChangeUS$ -0.1822
200 Day Percent Change-23.75%
Year to Date Price ChangeUS$ 0.005
Year to Date Percent Change0.86%

Aptose Biosciences Inc. (APTO) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.20
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio5.50
Leverage Ratio1.20
Quick Ratio5.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.10
Enterprise ValueUS$ 686,915
Price to Sales0.00
Price to Free Cash-2.30
PE High Last 5 Years-2.10
Price To Book1.20
Price To Cash Flow0.00
PE Low Last 5 Years-7.40
Price to Tangible Book1.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-80.56
Return on Equity-92.09
Return on Capital-82.89

Aptose Biosciences Inc. (APTO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOWilliam G. Rice
Emplyoees41
Last AuditUQ
CIK0000882361
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address251 Consumers Road
Suite 1105
Toronto, ON M2J 4R3
Websitehttps://www.aptose.com
Facsimile-
Telephone+1 650 718-5028
Emailir@aptose.com
Your Recent History
NASDAQ
APTO
Aptose Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 11:16:44